VVOS Vivos Therapeutics: שולי רווח תפעולי

Vivos Therapeutics (VVOS) maintains a strong position through its biomimetic, non-surgical treatment for apnea. The operating margin trend illustrates the effectiveness of this strategy, where -105.80 reflects the current value of the metric. The company is expanding its network of trained dentists, creating a unique treatment circuit. Insurance coverage for these services scales sales while optimizing distribution costs.
Vivos Therapeutics - פילוחים אנליטיים ומדדי מפתח (VVOS)

Vivos Therapeutics (VVOS) is scaling its presence in the apnea therapy segment, where growth in subscription checks directly impacts operating margins. This indicator reflects the portion of revenue remaining after covering all production costs before interest and taxes, allowing investors to assess the fundamental efficiency of the business model and the company's ability to generate internal cash flow.